Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis
Abstract Currently available rabies post‐exposure prophylaxis (PEP) for use in humans includes equine or human rabies immunoglobulins (RIG). The replacement of RIG with an equally or more potent and safer product is strongly encouraged due to the high costs and limited availability of existing RIG....
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Springer Nature
2016-03-01
|
| Ráidu: | EMBO Molecular Medicine |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.15252/emmm.201505986 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
